Concepedia

Robyn Widenmaier

RW

5

Publications

169

Citations

5

H-Index

2008

Active since

Affiliations

GlaxoSmithKline (United States)(Current)

GlaxoSmithKline (Belgium)

GlaxoSmithKline (Canada)

Robyn Widenmaier is an author at GlaxoSmithKline (United States) specializing in autoimmune disease, immunology, and cell signaling.

ORCID

Top concepts

Publications per year

2008–2025

5

Publications

5

Increased Risk of Herpes Zoster in Adults ≥50 Years Old Diagnosed With COVID-19 in the United States

Amit Bhavsar, Germain Lonnet, Chengbin Wang et al. · Open Forum Infectious Diseases · 2022 · 59 citations · Full text

Public Health Impact and Cost-Effectiveness of Non-live Adjuvanted Recombinant Zoster Vaccine in Canadian Adults

Ashleigh McGirr, Desirée Van Oorschot, Robyn Widenmaier et al. · Applied Health Economics and Health Policy · 2019 · 39 citations · Full text

Recombinant Adjuvanted Zoster Vaccine and Reduced Risk of Coronavirus Disease 2019 Diagnosis and Hospitalization in Older Adults

Katia Bruxvoort, Bradley K. Ackerson, Lina S. Sy et al. · The Journal of Infectious Diseases · 2021 · 38 citations · Full text

Transcriptional Inhibition of Interleukin-12 Promoter Activity in Leishmania Spp.–Infected Macrophages

Asha Jayakumar, Robyn Widenmaier, Xiaojing Ma et al. · Journal of Parasitology · 2008 · 21 citations

, , +17

Varicella-zoster virus reactivation and the risk of dementia

Vitaly Polisky, Maria Littmann, Aleksei Triastcyn et al. · Nature Medicine · 2025 · 12 citations · Full text

Rows per page

1–5 of 5